Cooper Companies Inc (COO) Stake Boosted by IFM Investors Pty Ltd

Share on StockTwits

IFM Investors Pty Ltd lifted its holdings in Cooper Companies Inc (NYSE:COO) by 25.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,128 shares of the medical device company’s stock after purchasing an additional 429 shares during the period. IFM Investors Pty Ltd’s holdings in Cooper Companies were worth $590,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of COO. LPL Financial LLC increased its stake in Cooper Companies by 15.1% during the first quarter. LPL Financial LLC now owns 5,354 shares of the medical device company’s stock valued at $1,225,000 after acquiring an additional 701 shares during the period. Allianz Asset Management GmbH increased its stake in Cooper Companies by 36.5% during the first quarter. Allianz Asset Management GmbH now owns 202,613 shares of the medical device company’s stock valued at $46,359,000 after acquiring an additional 54,143 shares during the period. Suntrust Banks Inc. increased its stake in Cooper Companies by 30.4% during the first quarter. Suntrust Banks Inc. now owns 2,667 shares of the medical device company’s stock valued at $609,000 after acquiring an additional 621 shares during the period. Brown Advisory Inc. increased its stake in Cooper Companies by 17.7% during the first quarter. Brown Advisory Inc. now owns 8,896 shares of the medical device company’s stock valued at $2,036,000 after acquiring an additional 1,338 shares during the period. Finally, Private Trust Co. NA increased its stake in Cooper Companies by 13.8% during the second quarter. Private Trust Co. NA now owns 4,153 shares of the medical device company’s stock valued at $977,000 after acquiring an additional 504 shares during the period. Institutional investors and hedge funds own 97.07% of the company’s stock.

Shares of COO opened at $258.31 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The stock has a market cap of $12.50 billion, a P/E ratio of 22.50, a PEG ratio of 2.04 and a beta of 0.67. Cooper Companies Inc has a 12-month low of $216.47 and a 12-month high of $280.10.

Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, August 30th. The medical device company reported $3.00 earnings per share for the quarter, missing analysts’ consensus estimates of $3.07 by ($0.07). The company had revenue of $660.00 million for the quarter, compared to analyst estimates of $653.44 million. Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%. Analysts anticipate that Cooper Companies Inc will post 11.62 EPS for the current fiscal year.

Several brokerages recently issued reports on COO. Zacks Investment Research upgraded Cooper Companies from a “sell” rating to a “hold” rating in a research note on Monday, October 1st. ValuEngine upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Thursday, September 27th. Raymond James boosted their price target on Cooper Companies from $270.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, September 21st. Oppenheimer set a $270.00 price target on Cooper Companies and gave the company a “hold” rating in a research note on Friday, August 31st. Finally, BMO Capital Markets boosted their price target on Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, August 31st. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $274.25.

In other Cooper Companies news, VP Randal Golden sold 1,731 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 27th. The stock was sold at an average price of $275.86, for a total transaction of $477,513.66. Following the sale, the vice president now directly owns 1,154 shares of the company’s stock, valued at $318,342.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert S. Weiss sold 58,543 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $252.82, for a total value of $14,800,841.26. Following the sale, the director now directly owns 157,710 shares in the company, valued at $39,872,242.20. The disclosure for this sale can be found here. Insiders have sold 80,809 shares of company stock worth $20,740,667 over the last ninety days. Company insiders own 1.60% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Asset Allocation Models, Which is Right For You?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply